F. Collin - Concepedia

Author

F. Collin

Centre Georges François Leclerc ORCID

Also Known As

Collin, F., F Collin, F. COLLIN, F. Collin, France Collin, François-David Collin, Fran�oise Collin

Publications

3.6K

Citations

H-Index

Concepts

All Affiliations

Centre Georges François Leclerc Institut Gustave Roussy Centre Léon Bérard Institut Bergonié European Organisation for Research and Treatment of Cancer

About

F. Collin is an author at Centre Georges François Leclerc specializing in medicine, pathology, and radiation oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	12	13	1.5K
2	Health Sciences	6	6	1.2K
3	Public Health	1	1	76
4	Biochemistry	1	1	76
5	Biology	1	1	76

F. Collin

Publications

Citations

H-Index

Page 1

	Year	Citations
Comparative study of the National Cancer Institute and French Federation of Cancer Centers Sarcoma Group grading systems in a population of 410 adult patients with soft tissue sarcoma. L Guillou, J.M. Coindre, F. Bonichon, Journal of Clinical Oncology Fnclcc SystemFnclcc SystemsFnclcc Grading SystemTumoral PathologySoft Tissue Sarcoma	1997	859
Prognostic factors in adult patients with locally controlled soft tissue sarcoma. A study of 546 patients from the French Federation of Cancer Centers Sarcoma Group. J.M. Coindre, Philippe Terrier, N.B. Bui, Journal of Clinical Oncology	1996	626
Phase II Study of ET-743 in Advanced Soft Tissue Sarcomas: A European Organisation for the Research and Treatment of Cancer (EORTC) Soft Tissue and Bone Sarcoma Group Trial Axel Le Cesne, Jean‐Yves Blay, Ian Judson, Journal of Clinical Oncology	2005	418
Evaluation of response after neoadjuvant treatment in soft tissue sarcomas; the European Organization for Research and Treatment of Cancer–Soft Tissue and Bone Sarcoma Group (EORTC–STBSG) recommendations for pathological examination and reporting Eva Wardelmann, Rick L. Haas, Judith V.M.G. Bovée, European Journal of Cancer Surgical OncologyTumoral PathologyBone Sarcoma GroupCancer–soft TissueMedicine	2015	146
High frequency of β-catenin heterozygous mutations in extra-abdominal fibromatosis: a potential molecular tool for disease management Julien Dômont, Sébastien Salas, Ludovic Lacroix, British Journal of Cancer	2010	130
Oncogenic osteomalacia: Diagnostic importance of fibroblast growth factor 23 and F-18 fluorodeoxyglucose PET/CT SCAN for the diagnosis and follow-up in one case J.L. Dupond, Hakim Mahammedi, Dominique Prié, Bone Bone DiseaseBone ImagingHealth SciencesDiagnostic ImportancePathology	2005	114
Hepatoid Adenocarcinoma of the Lung Laurent Arnould, F. Drouot, P. Fargeot, The American Journal of Surgical Pathology	1997	85
Two molecular forms of gonadotropin-releasing hormone from the brain of the frog, Rana ribibunda: purification, characterization, and distribution. J. Michael Conlon, F. Collin, Y. C. Chiang, Endocrinology Salmon GnrhNeuroendocrinologyReproductive BiologyGonadotropin-releasing HormoneReproductive Endocrinology	1993	76
A phase IIb multicentre study comparing the efficacy of trabectedin to doxorubicin in patients with advanced or metastatic untreated soft tissue sarcoma: The TRUSTS trial B. Bui-Nguyen, James E. Butrynski, Nicolas Penel, European Journal of Cancer Surgical OncologyOncologyTrusts TrialMetronomic TherapyPathology	2015	66
The role of surgery and treatment trends in uterine sarcoma L. Benoît, Laurent Arnould, N. Cheynel, European Journal of Surgical Oncology Gynecologic SurgerySurgical OncologyGynecological SurgeryGynecologySurgery	2005	56

Page 1